President and Chief Medical Officer Tracy George, MD, worked with ARUP’s PharmaDX and Clinical Trials group to create the central pathology review offering used in clinical trials for AYVAKIT. The new precision therapy for advanced systemic mastocytosis recently earned approval from the U.S. Food and Drug Administration.
Adam Barker, PhD, has been named ARUP’s first chief scientific officer. He moves into the role after having spent four years as director of Research and Development.
New Infectious Diseases Society of America guidelines, authored by a panel led by ARUP’s Kimberly Hanson, MD, MHS, describe the benefits and limitations of COVID-19 rapid antigen testing. The expert panel suggests that standard nucleic acid amplification testing should be used instead of rapid antigen tests in most circumstances when possible.
ARUP Chief Operations Officer Jonathan Genzen, MD, PhD (left), joined CEO Sherrie L. Perkins, MD, PhD, President Andy Theurer, and Board Chairman Peter Jensen, MD, on June 15, 2021, to cut a ceremonial ribbon to officially open ARUP’s new state-of-the-art laboratory facility in University of Utah Research Park.
A lab coordinator at Salt Lake City’s Fourth Street Clinic preps a patient to draw blood for laboratory testing. ARUP has renewed its agreement to provide testing free of charge to the clinic, which provides healthcare to homeless men, women, and children.
Photo credit: Fourth Street Clinic
Employees celebrate the opening of ARUP’s new bike storage facility on National Bike to Work Day, May 21. Employees pictured include (left to right) Bert Ley, Michael Juretich, Tom Martins, Stephen Merrigan, David Hillyard, Malia Deshotel, and Peta Owens-Liston.
ARUP Senior Pharmacy Consultant Ryan Nelson, PharmD, is the author of several papers aimed at helping oncologists use pharmacogenomic testing to guide treatment. He also will discuss the topic during a May 11, 2021, Patient-centered Laboratory Utilization Guidance Services/Medical Training Solutions (PLUGS/MTS) webinar.